TY  - GEN
AU  - Konstantinopoulos,Panagiotis A
AU  - Brady,William E
AU  - Farley,John
AU  - Armstrong,Amy
AU  - Uyar,Denise S
AU  - Gershenson,David M
TI  - Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
SN  - 1095-6859
PY  - 2018///0806
KW  - Adenocarcinoma, Clear Cell
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Anilides
KW  - administration & dosage
KW  - Fallopian Tube Neoplasms
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Ovarian Neoplasms
KW  - Peritoneal Neoplasms
KW  - Pyridines
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.ygyno.2018.04.572
ER  -